EPRX Competitors & Alternatives
Compare Eupraxia Pharmaceuticals Inc. Common Stock with similar stocks in the same industry
Pharmaceutical Preparations
EPRX
Main Stock$7.07
Tradestie Score
53
Market Cap
$307.12M
Analyst Upside
+103.7%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$921.46
|
$739.95B | 41.7 | 58 | Compare |
|
JNJ
Johnson & Johnson
|
$240.82
|
$448.07B | 22.1 | 64 | Compare |
|
ABBV
ABBVIE INC.
|
$205.45
|
$431.71B | 91.1 | 60 | Compare |
|
NVO
Novo-Nordisk A/S
|
$36.66
|
$262.92B | 10.2 | 62 | Compare |
|
AZN
AstraZeneca PLC
|
$203.49
|
$261.56B | 30.7 | 56 | Compare |
|
NVS
Novartis AG
|
$153.39
|
$254.99B | 21.7 | 59 | Compare |
|
ABT
Abbott Laboratories
|
$102.00
|
$232.30B | 27.5 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$120.62
|
$225.13B | 16.6 | 63 | Compare |
|
PFE
Pfizer Inc.
|
$27.88
|
$154.70B | 21.0 | 66 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.58
|
$121.27B | 20.5 | 61 | Compare |
More EPRX Analysis
Data updated: Apr 06, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry